July 2020
 
 
Business Involvement 
Methodology Overview 
 
MSCI ESG Research 
July 2020

BUSINESS INVOLVEMENT METHODOLOGY OVERVIEW
 JULY 2020
 
MSCI.COM | Page 2 of 18
© 2020 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document. 
 
 
 
Business Involvement Screening Research 
4 
Coverage Universe 
4 
Research Process 
5 
Ongoing Monitoring and Update Cycle 
5 
Corporate Actions 
5 
Additions and Deletions 
6 
Sources 
6 
Company Communication 
6 
Revenue 
6 
Quality Assurance 
7 
Business Involvement Screens 
7 
Abortion Providers 
7 
Abortifacients 
7 
Adult Entertainment 
8 
Alcohol 
8 
Animal Welfare 
8 
Biocides 
9 
Fur 
10 
For Profit Healthcare 
10 
Genetic Engineering 
11 
Lending Practices 
11 
CRA Rating 
12 
Nuclear Power 
12 
Palm Oil 
13 
Stem Cells 
13 
Tobacco 
13 
Defense and Weapons 
14 
Firearms 
14 
Cluster Munitions 
14 
Contents

BUSINESS INVOLVEMENT METHODOLOGY OVERVIEW
 JULY 2020
 
MSCI.COM | Page 3 of 18
© 2020 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document. 
 
Landmines 
14 
Global Weapons Production 
15 
Depleted Uranium Weapons 
15 
Blinding Laser Weapons 
15 
Incendiary Weapons 
15 
Non-detectable Fragments 
16 
Nuclear Weapons 
16 
Weapons General Exclusions 
16

BUSINESS INVOLVEMENT METHODOLOGY OVERVIEW
 JULY 2020
 
MSCI.COM | Page 4 of 18
© 2020 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document. 
 
Business Involvement Screening Research 
In order to help asset owners and managers ensure that their investment decisions 
comply with client mandates, MSCI ESG Research provides research on companies 
involved in specific business activities.  This summary is an abridge version of the 
methodology governing MSCI ESG Research’s Business Involvement Screening 
Research.  For more detail please see the full document. 
Coverage Universe 
The coverage universe for the MSCI Business Involvement Screening Research 
(BISR) in the below areas of involvement is comprised of global equity issuers, plus 
coverage for selected bond-issuing subsidiaries, selected corporate bond issuers 
and selected government-owned entities that operate as corporations 
- 
Abortion Providers,  
- 
Abortifacients,  
- 
Adult Entertainment,  
- 
Alcohol,  
- 
Animal Welfare,  
- 
Biocides, 
- 
Breast Milk Substitutes,  
- 
Cannabis,  
- 
Contraceptives,  
- 
Gambling,  
- 
Genetic Engineering,  
- 
Nuclear Power,  
- 
Pork,  
- 
Stem Cells,  
- 
Tobacco,  
- 
Defense and Weapons 
For other business involvement areas, the coverage is specified in the relevant 
sections below.

BUSINESS INVOLVEMENT METHODOLOGY OVERVIEW
 JULY 2020
 
MSCI.COM | Page 5 of 18
© 2020 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document. 
 
Research Process 
The MSCI ESG Research team includes a team of content specialists dedicated to 
producing research on controversial types of business involvement. These analysts 
are specialists responsible for identifying involvement in issue areas within a 
company.  
Using a combination of industry classifications, business descriptions, and keyword 
searches in select company filings, we identify issuers that could have potential 
involvement in each of the screening topics. If this initial review process identifies 
the potential for involvement, an analyst will review the company’s regulatory filings, 
annual reports, company websites and third-party sources, including news, media 
and non-governmental organizations, to determine if a company is in fact involved in 
one of the covered activities. If after this step there is no evidence to flag the 
company for one of the covered activities, then the company is also categorized as 
“Not Involved – Verified.” If during the screening process or analyst review evidence 
is captured relating to the companies’ involvement in a covered activity, then the 
company is categorized as “Involved.” 
Screens are designed only to flag companies with involvement in the covered 
activity and should not be used to produce comprehensive lists of companies 
without involvement. 
Ongoing Monitoring and Update Cycle 
MSCI ESG Research regularly reviews all companies in the coverage universe 
throughout the year, based on fiscal-year reporting cycles.  
Corporate Actions 
MSCI ESG Research analysts review and incorporate corporate actions to the 
research following the event’s completion. Corporate events include: acquisitions, 
consolidations, mergers, name changes, public offerings and spinoffs.  
Spin-offs: both the company that spins off operations as well as the new business 
entity are assessed to estimate the extent of their involvement in screened business 
activities (if any). 
Mergers and Acquisitions: We assess involvement in screened business activities for 
merged entities, acquiring companies and acquired companies.  
Name changes: The name of the company in our systems will reflect the new name; 
however the body of the company’s report may continue to reflect the old name until 
the company undergoes scheduled data review.

BUSINESS INVOLVEMENT METHODOLOGY OVERVIEW
 JULY 2020
 
MSCI.COM | Page 6 of 18
© 2020 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document. 
 
Additions and Deletions 
Companies are added to or removed from MSCI ESG Research Business Involvement 
Screens under the following circumstances:  
• 
If MSCI ESG Research determines conclusively that the company is no 
longer involved with the relevant activity.  
• 
In the event that there is no conclusive evidence of either continued 
involvement or a discontinuation of involvement in a subject activity, MSCI 
ESG Research retains a company’s involvement flags for up to three years. 
After this period, if there is no evidence of continued involvement, MSCI 
ESG Research considers the company no longer involved.  
Sources 
MSCI ESG Research uses a wide range of information tools and sources, including: 
• 
Company websites, 
• 
Company annual reports and regulatory filings, 
• 
Media search services, 
• 
Business directories, 
• 
Nongovernmental organization (NGO) reports and websites, 
• 
Government agencies and disclosures, 
• 
Financial data providers, and 
• 
Direct communication with company. 
Company Communication 
MSCI ESG Research seeks input from every company that is included in any of the 
business involvement screens when its information is updated, at a minimum of 
once a year. Where MSCI ESG Research has the e-mail contact information, the 
companies are invited to review MSCI ESG Research’s assessments and reports, and 
to provide updates, clarifications and comments. Information provided by companies 
during this process is reviewed by analysts and incorporated into the research as 
appropriate.  
Revenue 
MSCI ESG Research provides company revenue percentages for companies with 
certain types of business activity. Where the revenue for a covered business activity 
is not disclosed by a company and is not available through other publicly available 
sources, a revenue estimate is supplied.

BUSINESS INVOLVEMENT METHODOLOGY OVERVIEW
 JULY 2020
 
MSCI.COM | Page 7 of 18
© 2020 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document. 
 
Revenue Estimation Process 
When companies do not report exact revenue figures for a covered business activity, 
MSCI ESG Research provides an estimate of the extent of companies’ involvement in 
the subject activity. The estimation approach is as follows:  
• 
The reported business segment of the business involvement activity is 
identified.  
• 
The other activities in that segment(s) are determined and considered in 
order to calculate the estimated revenue for said business involvement 
activity. All available disclosures are considered.  
• 
In the absence of information indicating otherwise, assumptions are made 
that product lines are of equal weight in terms of revenue contribution.  
Quality Review 
Initial company research and analysis is followed by a rigorous quality review 
process. Data accuracy and company profiles are peer-reviewed, then sent to content 
leads for final approval. In specific cases in which a company’s business activity is 
not clearly defined by MSCI ESG Research’s methodology and there is no precedent, 
the case is escalated to the Head of Screening Research. Cases that require further 
interpretation or an update to the methodology are brought to the MSCI ESG Impact 
and Screening Methodology Committee for resolution. 
Business Involvement Screens 
Abortion Providers 
MSCI ESG Research’s abortion provider research identifies companies that own or 
operate facilities where abortions are performed. Companies are not placed on the 
Abortion Provider screen unless MSCI ESG Research has received confirmation from 
the company within the last three fiscal years that an abortion has been performed at 
a company facility.  
In addition, MSCI ESG Research identifies companies that own or operate acute care 
facilities with the capacity to perform abortions. 
Abortifacients 
MSCI ESG Research’s abortifacients research identifies companies that manufacture 
abortifacient products. The research describes both the type of involvement and the 
revenue from that involvement.  
An abortifacient is defined as any drug, compound or chemical that results in the 
termination of pregnancy by causing the cervix to dilate and the uterus to

BUSINESS INVOLVEMENT METHODOLOGY OVERVIEW
 JULY 2020
 
MSCI.COM | Page 8 of 18
© 2020 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document. 
 
prematurely contract. MSCI ESG Research includes drugs or other agents primarily 
designed or approved for use in the termination of pregnancy, as well as drugs or 
other agents recognized by medical authorities as having a significant secondary use 
in the termination of pregnancy, including methotrexate, misoprostol, oxytocin, 
dinoprost, hemabate (carboprost), RU 486 (mifepristone) or gemeprost. 
In addition, MSCI ESG Research identifies companies that own or operate acute care 
facilities with the capacity to perform abortions. 
Adult Entertainment 
MSCI ESG Research’s adult entertainment research identifies companies that are 
involved in the production, distribution or retailing of adult entertainment products. 
The research describes both the type of involvement and the revenue from that 
involvement. The total revenue derived from adult entertainment is available, as well 
as revenue derived from each of the following subcategories: producer, retailer and 
distributor.   
MSCI ESG Research defines adult entertainment products as material in which the 
dominant theme is “sexually explicit” conduct, specifically the depiction or 
description of sexual or excretory activities in a lascivious way. MSCI ESG Research 
uses the term “adult entertainment” interchangeably with “sexually explicit material” 
and “sexually explicit adult entertainment.” 
Alcohol 
MSCI ESG Research’s alcohol research identifies companies that produce, distribute, 
retail, license or supply alcoholic beverages, key products and services. The research 
describes both the type of involvement and the revenue from that involvement. The 
total revenue derived from alcohol is available, as well as revenue derived from each 
of the following subcategories: producer, distributor, supplier, retailer, and licensor.   
An alcoholic beverage is defined as any fermented liquor that contains ethyl alcohol 
or ethanol as an intoxicating agent. MSCI ESG Research captures beverages with any 
amount of alcoholic content. 
Animal Welfare 
MSCI ESG Research’s animal welfare research identifies companies involved in 
testing products or product ingredients of any sort on animals, breeding animals for 
animal testing purposes, exhibiting animals and operating factory farms. MSCI ESG 
Research includes publicly traded companies that perform testing activities in-house, 
as well as those that outsource that testing to third parties.

BUSINESS INVOLVEMENT METHODOLOGY OVERVIEW
 JULY 2020
 
MSCI.COM | Page 9 of 18
© 2020 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document. 
 
Animal Welfare research refers to the research and testing performed on animals to 
determine safety and efficacy of specific products; factory farming; and the breeding 
and exhibiting of animals. 
Biocides 
MSCI ESG Research’s biocides research identifies companies that are involved in the 
production or the supply of chemicals that are used to control unwanted organisms.  
The total revenue derived from biocides is available, as well as revenue derived from 
each of the following subcategories: supplier and producer.  
Biocides are defined as products that are used to control unwanted organisms. 
These include pesticides, rodenticides, insecticides, and antifouling products.  
Breast Milk Substitutes 
MSCI ESG Research’s BMS screen identifies companies that have been flagged by 
the International Baby Food Action Network (IBFAN) as violating the International 
Code of Marketing of Breast Milk Substitutes. 
Cannabis 
MSCI ESG Research’s Cannabis research identifies companies that are involved in 
the production, retailing or pharmaceutical research of cannabis. The research 
describes both the type of involvement and the revenue from that involvement. The 
total revenue derived from cannabis is available, as well as revenue derived from 
each of the following subcategories: producer and retailer.   
Cannabis products and derivatives usually come from the dried leaves and flowers of 
the Cannabis sativa or Cannabis indica plant. It has a psychoactive substance that 
can be used for both medicinal and recreational use. Its main psychoactive chemical 
component, tetrahydrocannabinol (THC), works as an anti-emetic drug that is 
effective against vomiting and nausea during medical treatments. Additionally, THC 
can also induce a euphoric high, which lets users experience a state of relaxation. 
Consumption of Cannabis is most commonly done through smoking, vaporizing or 
ingestion by mixing with food. It is also known as marijuana, weed, grass, ganja, bud, 
hash, pot, blunts, or joint.  
Note that companies that produce or retail products that are CBD-based and do not 
contain significant amounts of THC, and companies that manufacture 
miscellaneous paraphernalia (such as pipes, bonds, hookahs, papers, etc) are 
excluded from this screen.

BUSINESS INVOLVEMENT METHODOLOGY OVERVIEW
 JULY 2020
 
MSCI.COM | Page 10 of 18
© 2020 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document. 
 
Contraceptives 
MSCI ESG Research’s contraceptives research identifies companies that 
manufacture or license their company brand name to contraceptive products. The 
research describes both the type of involvement and the revenue from that 
involvement. 
Contraception is defined as the prevention of fertilization of the ovum by sperm cells.  
Note that retailers of contraceptives are excluded from this screen. 
Fur 
MSCI ESG Research’s fur screen identifies companies that derive any detectable 
revenues from the production and/or sale of fur products, including those that raise, 
trap or slaughter animals for their fur as well as those deriving revenue from the sale 
of products made from or incorporating fur, such as coats, muffs, hats and stoles, as 
well as home décor, craft supplies, etc. The total revenue derived from fur is 
available, as well as revenue derived from each of the following subcategories: 
producer and retailer.   
MSCI ESG Research’s definition of fur includes shearling and astrakhan. Leather is 
not included in the screen. 
Coverage Universe: MSCI ACWI IMI 
For Profit Healthcare 
MSCI ESG Research’s for-profit healthcare screen identifies companies with ties to 
abortion or birth control, including HMOs that offer coverage for these products and 
services, as well as companies offering standard healthcare services.  
Coverage Universe: MSCI World excluding US + US Top 3,000 
For Profit Prisons 
MSCI ESG Research’s For-Profit Prisons screen identifies companies that derive any 
detectable revenue from the operation of private prisons, jails, detention centers or 
correctional facilities or from the provision of integral services to these types of 
facilities. Integral services include: complete facilities management (end-to-end), 
security services and detention services. For-Profit Prisons may be alternatively 
known as private prisons.  The total revenue derived from for profit prisons is 
available. 
Note that companies that provide supplemental services to for-profit prisons (such 
as cleaning, catering, recreational programs, rehabilitation, probation, etc.) are 
excluded from this screen.

BUSINESS INVOLVEMENT METHODOLOGY OVERVIEW
 JULY 2020
 
MSCI.COM | Page 11 of 18
© 2020 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document. 
 
Coverage Universe: MSCI ACWI IMI 
 
Gambling 
MSCI ESG Research’s gambling research identifies companies that own or operate 
gambling facilities or provide support or services to the gambling industry. The 
research describes both the type of involvement and the revenue from that 
involvement. The total revenue derived from gambling is available, as well as revenue 
derived from each of the following subcategories: operations, support services, and 
licensing agreements.   
Gambling is defined as the betting or staking of money or something of value, with 
consciousness of risk and hope of gain, on the outcome of a game, a contest or an 
event, the outcome of which is determined by chance. 
Note that companies that only own property on which casinos are located or 
companies that lease land or space on which casinos are operated are excluded 
from this screen. 
Genetic Engineering 
MSCI ESG Research’s genetic engineering research includes companies that 
genetically modify organisms (GMOs) for agricultural use or human consumption. 
Specifically, this includes companies that have filed for a notification with the USDA’s 
Animal and Plant Health Inspection Service (APHIS) for field testing of organisms 
engineered to produce compounds intended for agricultural use; companies included 
in the European Union (EU) – Food Safety Administration (EFSA) list that have 
applied for permits to market genetically engineered material for food or food 
additives in the EU; and companies found in the GM crop database from the Center 
for Environmental Risk Assessment (CERA).  
Note that companies that use genetically modified ingredients in their products, 
and companies that retail foodstuffs that contain genetically modified organisms as 
an ingredient are excluded from this screen. 
Lending Practices 
Controversial lending practices are defined as those in which lenders take advantage 
of borrowers’ lack of understanding and/or lack of access to more traditional 
financial services to impose loan terms that place a disproportionately and often 
untenably high burden on the borrower. This is often done through deception, fraud, 
or manipulation via aggressive sales tactics.

BUSINESS INVOLVEMENT METHODOLOGY OVERVIEW
 JULY 2020
 
MSCI.COM | Page 12 of 18
© 2020 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document. 
 
Lending Practices 
MSCI ESG Research’s Lending Practices research is designed to identify companies 
involved in the provision of products and services associated with controversial 
lending practices including payday loans, installment loans, pawn loans, title loans, 
tax refund anticipation loans, and doorstep loans. In addition, the total revenue 
derived from the above activities is available.   
Lending Controversy Ties 
The Lending Practices research also identifies companies with severe or very severe 
controversies within the past three years related to consumer lending such as 
allegations of usurious interest payments, discriminatory lending practices, or 
deceptive or dubious home loan or subprime mortgage marketing practices. 
Coverage Universe: MSCI ACWI and US Top 3000 by Market Cap 
CRA Rating 
MSCI ESG Research also provides a list of companies that are given a "Needs to 
improve" or "Substantial Noncompliance" rating under the Community Reinvestment 
Act (CRA) of the United States. 
The CRA is intended to encourage depository institutions to help meet the credit 
needs of the communities in which they operate, including low- and moderate 
income neighborhoods, consistent with safe and sound banking operations. 
U.S. financial institutions that received a rating of "Needs to improve" or "Substantial 
Noncompliance" after taking the CRA examination within the last three years. 
Nuclear Power 
MSCI ESG Research’s nuclear power research is designed to identify companies that 
own or operate nuclear power plants, and manufacture and supply key products or 
services to the nuclear power industry. The research describes the type of 
involvement, the company's percentage of power generation derived from nuclear 
sources, percentage of total nuclear installed capacity and the revenue from nuclear 
power-related activities. The total revenue derived from nuclear power is available, as 
well as revenue derived from each of the following subcategories: utility, supplier, 
and uranium mining.   
Note companies that provide generic / non-essential components (such as nuts, 
bolts, screws, wiring, etc.) or raw materials (such as metal or steel) are excluded 
from this screen.

BUSINESS INVOLVEMENT METHODOLOGY OVERVIEW
 JULY 2020
 
MSCI.COM | Page 13 of 18
© 2020 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document. 
 
Palm Oil 
MSCI ESG Research’s Palm Oil Screen identifies companies that are involved in the 
production and distribution of palm oil products. The research describes both the 
type of involvement and the revenue from that involvement. The total revenue 
derived from palm oil is available, as well as revenue derived from each of the 
following subcategories: Producer and Distributor.  In addition, MSCI ESG Research 
monitors the Round Table for Sustainable Palm Oil (RSPO) Annual Communication of 
Progress Reports that indicate palm oil plantation certification to RSPO’s standards. 
MSCI ESG Research defines palm oil as a yield of the African oil palm or Elaeis 
guineensis Jacq. The oil can either be extracted from the flesh of the fruit of the 
palm or the crushed extract of the kernel of the fruit. 
Note that companies that manufacture or sell products that use palm oil as an 
ingredient are excluded from this screen. 
Coverage Universe: MSCI ACWI IMI 
Pork 
MSCI ESG Research’s pork research identifies companies that are involved in the 
production of pork products, including pig breeding, slaughtering and processing 
meat and food products with pork ingredients. The research also includes 
companies with significant retailing and distribution activities. The total revenue 
derived from pork is available, as well as revenue derived from each of the following 
subcategories: Producer and Retailer.   
Pork is the culinary name for meat from the domestic pig (swine or Sus domesticus). 
Stem Cells 
MSCI ESG Research’s stem cell research identifies companies that conduct research 
using stem cells derived from human embryos, human fetal tissue or human adult 
tissue. MSCI ESG Research also identifies publicly traded companies with research 
partnerships or collaborations that conduct stem cell research through a third party; 
companies using human fetal cell lines; and companies that produce technology or 
products that enable stem cell research.  
Tobacco 
MSCI ESG Research’s tobacco research identifies companies that produce, 
distribute, retail, license or supply key tobacco products and services. The research 
describes both the type of involvement and the revenue from that involvement. The 
total revenue derived from tobacco is available, as well as revenue derived from each 
of the following subcategories: Producer, Distributor, Retailer, Licensor and Supplier.

BUSINESS INVOLVEMENT METHODOLOGY OVERVIEW
 JULY 2020
 
MSCI.COM | Page 14 of 18
© 2020 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document. 
 
Tobacco is produced from the dried nicotina plant. 
Defense and Weapons 
MSCI ESG Research’s Defense and Weapons research includes companies that are 
involved in the production of civilian Firearms, Controversial and Conventional 
Military Weapons. Defense and Weapons screens available are listed below: 
Firearms 
MSCI ESG Research’s Firearms research identifies companies that manufacture 
handguns, pistols, shotguns, rifles, revolvers, and ammunition for civilian (non-
military) use. The research describes both the type of involvement and the revenue 
from that involvement.  
Firearms are devices capable of firing a projectile and using an explosive charge as a 
propellant. 
Note that companies manufacturing firearm / ammunition components, firearm 
accessories (such as scopes, mounts, gun cases, etc.), and air rifles are excluded 
from this screen. 
Cluster Munitions 
MSCI ESG Research's Cluster Munitions screen identifies companies involved in the 
production of cluster munitions, components and delivery platforms. The research 
may also include select significant or notable private companies. The following 
definitions are used: 
Cluster munition: a bomb, missile, rocket or shell that carries submunitions and 
disperses them over an area 
Submunition: a small bomb contained with other submunitions in a cluster munition. 
The submunition is designed to detonate prior to, on, or after impact. 
Cluster munition component: an integral part to the basic function of a cluster 
munition weapon system. It may also provide added lethality, precision or other 
functionalities, such as targeting, guidance and navigation.  
Cluster munition delivery platform: an independent weapons system capable of 
carrying and deploying cluster munitions to the designated target area. Delivery 
platforms can include self-propelled rocket launcher systems and aircraft. 
Landmines 
MSCI ESG Research's Landmines Screen identifies companies involved in the 
production of anti-personnel landmines (APMs), components and anti-vehicle

BUSINESS INVOLVEMENT METHODOLOGY OVERVIEW
 JULY 2020
 
MSCI.COM | Page 15 of 18
© 2020 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document. 
 
landmines. The research may also include select significant or notable private 
companies.  The following definitions are used: 
Anti-personnel landmine: a munition that is placed under, on, or near the ground or 
other surface area and explodes by the presence, proximity or contact with a person 
or upon command by an operator from a remote location.  
Anti-personnel landmine component: an integral component to the basic function of 
the weapon. It may also provide added lethality, precision or other functionalities to 
the weapon. 
Anti-vehicle landmine: munition that is placed under, on, or near the ground or other 
surface area and explodes by the presence, proximity or contact with a vehicle. 
MSCI ESG Research also considers and includes weapons or munitions that fulfill the 
same function, role and/or purpose as landmines. 
Global Weapons Production 
MSCI ESG Research’s weapons research identifies companies that manufacture 
military weapons systems and weapons components. The research describes both 
the type of involvement and the revenue from that involvement. MSCI ESG 
Research’s weapons research distinguishes between involvement in whole weapons 
systems and components of those systems. Additionally, the research includes 
recent-year percentage of revenue for the following main categories: Conventional 
Weapons and Components, Chemical and Biological Weapons and Components, 
Nuclear Weapons and Components, and Support Systems and Services. Analysts 
capture each company’s total revenue from weapons, including both weapons-
specific DOD contract revenue, if applicable, and all other sources of weapons 
revenue. 
Depleted Uranium Weapons 
MSCI ESG Research’s Depleted Uranium research identifies companies that 
manufacture weapons, ammunition and armor made with Depleted Uranium (DU) 
and DU alloys. DU is a by-product of the uranium-enrichment process used to make 
nuclear weapons and nuclear-reactor fuel. The U.S. Nuclear Regulatory Commission 
defines depleted uranium as uranium whose percentage fraction by weight of the U-
235 isotope is less than 0.711%. 
Blinding Laser Weapons 
MSCI ESG Research’s Blinding Laser Weapons’ research identifies companies that 
manufacture weapons using laser technology that causes permanent blindness to 
the target.

BUSINESS INVOLVEMENT METHODOLOGY OVERVIEW
 JULY 2020
 
MSCI.COM | Page 16 of 18
© 2020 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document. 
 
Incendiary Weapons 
MSCI ESG Research’s incendiary weapons research identified companies that 
manufacture incendiary weapons using white phosphorus. 
Non-detectable Fragments 
Non-Detectable Fragments Weapons are defined as any weapon with a primary 
effect to injure with fragments that cannot be detected by X-rays once inside the 
human body. 
Nuclear Weapons 
MSCI ESG Research's Nuclear Weapons screen identifies companies with different 
types of ties to nuclear weapons including warheads and missiles, delivery platforms, 
weapon components, and support / service providers. 
Weapons General Exclusions 
Companies that are involved in the production of generic or dual use components to 
weapons systems, military material (such as  uniforms, footwear, foodstuffs), 
supporting vehicles that do not have an offensive capability, and raw materials are 
excluded from this screen.

July 2020
 
 
 
AMERICAS 
Americas 
1 888 588 4567 * 
Atlanta  
+ 1 404 551 3212 
Boston  
+ 1 617 532 0920 
Chicago 
+ 1 312 675 0545 
Monterrey 
+ 52 81 1253 4020 
New York 
+ 1 212 804 3901 
San Francisco + 1 415 836 8800 
São Paulo 
+ 55 11 3706 1360 
Toronto 
+ 1 416 628 1007 
EUROPE, MIDDLE EAST & AFRICA 
Cape Town 
+ 27 21 673 0100 
Frankfurt 
+ 49 69 133 859 00 
Geneva  
+ 41 22 817 9777 
London  
+ 44 20 7618 2222 
Milan  
+ 39 02 5849 0415 
Paris 
 
0800 91 59 17 * 
ASIA PACIFIC 
China North 
10800 852 1032 * 
China South 
10800 152 1032 * 
Hong Kong 
+ 852 2844 9333 
Mumbai 
+ 91 22 6784 9160 
Seoul  
00798 8521 3392 * 
Singapore 
800 852 3749 * 
Sydney  
+ 61 2 9033 9333 
Taipei  
008 0112 7513 * 
Thailand 
0018 0015 6207 7181 * 
Tokyo  
+ 81 3 5290 1555 
 
* =  toll free 
ABOUT MSCI 
MSCI is a leading provider of critical 
decision support tools and services for 
the global investment community. With 
over 45 years of expertise in research, 
data and technology, we power better 
investment decisions by enabling clients 
to understand and analyze key drivers of 
risk and return and confidently build 
more effective portfolios. We create 
industry-leading research-enhanced 
solutions that clients use to gain insight 
into and improve transparency across the 
investment process. 
About MSCI ESG Research Products and 
Services 
MSCI ESG Research products and 
services are provided by MSCI ESG 
Research LLC, and are designed to 
provide in-depth research, ratings and 
analysis of environmental, social and 
governance-related business practices to 
companies worldwide. ESG ratings, data 
and analysis from MSCI ESG Research 
LLC. are also used in the construction of 
the MSCI ESG Indexes. MSCI ESG 
Research LLC is a Registered Investment 
Adviser under the Investment Advisers 
Act of 1940 and a subsidiary of MSCI Inc. 
To learn more, please visit 
www.msci.com. 
 
 
 
 
 
Contact us
clientservice@msci.com

BUSINESS INVOLVEMENT METHODOLOGY OVERVIEW
 JULY 2020
MSCI.COM | Page 18 of 18
© 2020 MSCI Inc. All rights reserved. 
 
Notice and disclaimer 
 
This document and all of the information contained in it, including without limitation all text, data, graphs, charts (collectively, the “Information”) is the property of MSCI Inc. or its subsidiaries 
(collectively, “MSCI”), or MSCI’s licensors, direct or indirect suppliers or any third party involved in making or compiling any Information (collectively, with MSCI, the “Information Providers”) 
and is provided for informational purposes only. The Information may not be modified, reverse-engineered, reproduced or redisseminated in whole or in part without prior written permission 
from MSCI. All rights in the Information are reserved by MSCI and/or its Information Providers. 
 
The Information may not be used to create derivative works or to verify or correct other data or information. For example (but without limitation), the Information may not be used to create 
indexes, databases, risk models, analytics, software, or in connection with the issuing, offering, sponsoring, managing or marketing of any securities, portfolios, financial products or other 
investment vehicles utilizing or based on, linked to, tracking or otherwise derived from the Information or any other MSCI data, information, products or services. 
 
The user of the Information assumes the entire risk of any use it may make or permit to be made of the Information. NONE OF THE INFORMATION PROVIDERS MAKES ANY EXPRESS OR 
IMPLIED WARRANTIES OR REPRESENTATIONS WITH RESPECT TO THE INFORMATION (OR THE RESULTS TO BE OBTAINED BY THE USE THEREOF), AND TO THE MAXIMUM EXTENT 
PERMITTED BY APPLICABLE LAW, EACH INFORMATION PROVIDER EXPRESSLY DISCLAIMS ALL IMPLIED WARRANTIES (INCLUDING, WITHOUT LIMITATION, ANY IMPLIED WARRANTIES 
OF ORIGINALITY, ACCURACY, TIMELINESS, NON-INFRINGEMENT, COMPLETENESS, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE) WITH RESPECT TO ANY OF THE 
INFORMATION. 
 
Without limiting any of the foregoing and to the maximum extent permitted by applicable law, in no event shall any Information Provider have any liability regarding any of the Information 
for any direct, indirect, special, punitive, consequential (including lost profits) or any other damages even if notified of the possibility of such damages. The foregoing shall not exclude or 
limit any liability that may not by applicable law be excluded or limited, including without limitation (as applicable), any liability for death or personal injury to the extent that such injury results 
from the negligence or willful default of itself, its servants, agents or sub-contractors. 
 
Information containing any historical information, data or analysis should not be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. Past 
performance does not guarantee future results. 
 
The Information should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment 
and other business decisions. All Information is impersonal and not tailored to the needs of any person, entity or group of persons. 
 
None of the Information constitutes an offer to sell (or a solicitation of an offer to buy), any security, financial product or other investment vehicle or any trading strategy. 
 
It is not possible to invest directly in an index. Exposure to an asset class or trading strategy or other category represented by an index is only available through third party investable 
instruments (if any) based on that index. MSCI does not issue, sponsor, endorse, market, offer, review or otherwise express any opinion regarding any fund, ETF, derivative or other security, 
investment, financial product or trading strategy that is based on, linked to or seeks to provide an investment return related to the performance of any MSCI index (collectively, “Index Linked 
Investments”). MSCI makes no assurance that any Index Linked Investments will accurately track index performance or provide positive investment returns. MSCI Inc. is not an investment 
adviser or fiduciary and MSCI makes no representation regarding the advisability of investing in any Index Linked Investments. 
 
Index returns do not represent the results of actual trading of investible assets/securities. MSCI maintains and calculates indexes but does not manage actual assets. Index returns do not 
reflect payment of any sales charges or fees an investor may pay to purchase the securities underlying the index or Index Linked Investments. The imposition of these fees and charges 
would cause the performance of an Index Linked Investment to be different than the MSCI index performance. 
 
The Information may contain back tested data. Back-tested performance is not actual performance but is hypothetical. There are frequently material differences between back tested 
performance results and actual results subsequently achieved by any investment strategy. 
 
Constituents of MSCI equity indexes are listed companies, which are included in or excluded from the indexes according to the application of the relevant index methodologies. Accordingly, 
constituents in MSCI equity indexes may include MSCI Inc., clients of MSCI or suppliers to MSCI. Inclusion of a security within an MSCI index is not a recommendation by MSCI to buy, sell, 
or hold such security, nor is it considered to be investment advice. 
 
Data and information produced by various affiliates of MSCI Inc., including MSCI ESG Research LLC and Barra LLC, may be used in calculating certain MSCI indexes. More information can 
be found in the relevant index methodologies on www.msci.com. 
 
MSCI receives compensation in connection with licensing its indexes to third parties. MSCI Inc.’s revenue includes fees based on assets in Index Linked Investments. Information can be 
found in MSCI Inc.’s company filings on the Investor Relations section of www.msci.com. 
 
MSCI ESG Research LLC is a Registered Investment Adviser under the Investment Advisers Act of 1940 and a subsidiary of MSCI Inc. Except with respect to any applicable products or 
services from MSCI ESG Research, neither MSCI nor any of its products or services recommends, endorses, approves or otherwise expresses any opinion regarding any issuer, securities, 
financial products or instruments or trading strategies and MSCI’s products or services are not intended to constitute investment advice or a recommendation to make (or refrain from 
making) any kind of investment decision and may not be relied on as such. Issuers mentioned or included in any MSCI ESG Research materials may include MSCI Inc., clients of MSCI or 
suppliers to MSCI, and may also purchase research or other products or services from MSCI ESG Research. MSCI ESG Research materials, including materials utilized in any MSCI ESG 
Indexes or other products, have not been submitted to, nor received approval from, the United States Securities and Exchange Commission or any other regulatory body. 
 
Any use of or access to products, services or information of MSCI requires a license from MSCI. MSCI, Barra, RiskMetrics, IPD and other MSCI brands and product names are the trademarks, 
service marks, or registered trademarks of MSCI or its subsidiaries in the United States and other jurisdictions. The Global Industry Classification Standard (GICS) was developed by and is 
the exclusive property of MSCI and Standard & Poor’s. “Global Industry Classification Standard (GICS)” is a service mark of MSCI and Standard & Poor’s. 
 
MIFID2/MIFIR notice: MSCI ESG Research LLC does not distribute or act as an intermediary for financial instruments or structured deposits, nor does it deal on its own account, provide 
execution services for others or manage client accounts. No MSCI ESG Research product or service supports, promotes or is intended to support or promote any such activity. MSCI ESG 
Research is an independent provider of ESG data, reports and ratings based on published methodologies and available to clients on a subscription basis. We do not provide custom or one-
off ratings or recommendations of securities or other financial instruments upon request. 
 
Privacy notice: For information about how MSCI collects and uses personal data, please refer to our Privacy Notice at https://www.msci.com/privacy-pledge.